« Dr. David Applegate, Senior Science Advisor for Earthquake and Geologic Hazards, U.S. Geological Survey, 8/5/05 | Main | Dr. Alan P. Zelicoff, author, MICROBE: Are We Ready for the Next Plague?, 11/2/05 »
November 03, 2005
Dr. Albert Deisseroth, President and CEO, Sidney Kimmel Cancer Center, 11/2/05
Dr. Albert Deisseroth is best known for the development of new directions in the treatment of leukemias and solid tumors through the use of molecular targeting and genetic therapy. Currently he is launching genetic therapy trials for vascular targeting therapy and vaccine therapy of epithelial neoplasms. He is also involved with vector mediated chemotherapy sensitization that is tumor specific, a method designed to decrease toxicity and adverse side effects while at the same time increasing the efficacy of responses produced.
Dr. Deisseroth is the author of nearly 400 articles and reports on cancer research. He has served or currently serves on the editorial boards of Contemporary Oncology, Cancer Research, Somatic Cell and Molecular Genetics, Blood, Cancer, Cancer Research, The Cancer Journal, Clinical Cancer Research, Human Gene Therapy, and Cancer Gene Therapy.
Founded in 1990, the Sidney Kimmel Cancer Center is a nonprofit research institute dedicated to the development of advanced biological cancer treatments, such as gene therapy, angiostatic therapy, vaccine therapy, and immunotherapy, and to making those treatments readily available to patients. The National Cancer Institute ranks SKCC as one of the top three cancer centers in the United States in the application of genomics and proteomics to the treatment of specific cancers.
Posted by David Lemberg at November 3, 2005 03:45 PM Return to SCIENCE AND SOCIETY home page